At Exam 5 (2010–2012), MESA participants without contraindications underwent CMR using 1.5T scanners (Avanto and Espree, Siemens Medical Systems; Signa LX, GE Healthcare). The MESA CMR protocol has been described previously and was uniform across all study sites.18 (link) Briefly, LV volumes, myocardial mass, and functional measures were assessed by a cine steady‐state free precession sequence. Twelve short axis slices, one 4‐chamber view and one 2‐ chamber view, were acquired as described previously. Additionally, 3 tagged short-axis slices (base, mid, apex) were additionally obtained. The protocol for tagged CMR has been previously described.19 (link) Finally, a subset (n=1,342) of consenting participants with estimated glomerular filtration rates (eGFR) >60 mL/min/1.73m2 (Northwestern study site) or >45 mL/min/1.73m2 (remaining study sites) underwent late gadolinium enhanced (LGE) CMR 15 minutes after administration of 0.15 mmol/kg dose of gadolinium based contrast agent (Magnevist, Bayer Healthcare Pharmaceuticals, Montville, NJ). All MESA CMR images were analyzed for structure and function in a core laboratory and at a single image analysis center (Johns Hopkins Medical Center, Baltimore, MD).